NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

原代細胞市場:原料·種類·終端用戶·不同地區的預測 - 市場佔有率·市場規模·趨勢·產業分析(2021年∼2028年)

Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type ; By End-Use ; By Source; By Regions; Segment Forecast, 2021 - 2028

出版商 Polaris Market Research 商品編碼 1004374
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
原代細胞市場:原料·種類·終端用戶·不同地區的預測 - 市場佔有率·市場規模·趨勢·產業分析(2021年∼2028年) Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type ; By End-Use ; By Source; By Regions; Segment Forecast, 2021 - 2028
出版日期: 2021年04月01日內容資訊: 英文 112 Pages
簡介

全球原代細胞市場市場規模在2028年之前預測將達到17億9,000萬美元。

生物醫學研究投資的增加、癌症發病率的增加、對先進藥物開發和測試的需求增加、基因工程和病毒學的應用擴大、對動物試驗的嚴格規定等,正在推動這一市場的增長。此外,醫療和製藥領域的顯著增長、技術進步以及原代細胞在幹細胞治療中的使用增加,預計將為市場帶來增長機會。

本報告提供全球原代細胞市場相關調查,提供市場概要,原料·種類·終端用戶·各地區的市場規模的變化與預測,市場推動要素·阻礙因素分析,市場機會,課題,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 報告概要
    • 調查目的
    • 市場規模
    • 假設
  • 相關利益者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 一級資訊來源
    • 二級資訊來源

第4章 市場洞察

  • 產業概述
  • 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力
    • 新加入廠商者的威脅
    • 買方議價能力
    • 替代品的威脅
    • 競爭企業間的敵對關係
  • 大環境分析
  • 價值鏈分析
  • 產業趨勢

第5章 原代細胞市場:各原料

  • 主要調查結果
  • 簡介
    • 市場規模:各原料(實際成果值·預測值)
  • 動物第一代細胞
  • 人第一代細胞

第6章 原代細胞市場:各類型

  • 主要調查結果
  • 簡介
    • 市場規模:各類型(實際成果值·預測值)
  • 造血細胞
  • 幹細胞
  • 腎細胞
  • 消化管細胞
  • 皮膚細胞
  • 胚細胞
  • 其他

第7章 原代細胞市場:各終端用戶

  • 主要調查結果
  • 簡介
    • 市場規模:各終端用戶(實際成果值·預測值)
  • 醫療
  • 製藥·生物科技
  • 研究機關
  • 其他

第8章 原代細胞市場:各地區

  • 主要調查結果
  • 簡介
  • 北美
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 美國
    • 加拿大
  • 歐洲
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 南美
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 墨西哥
    • 巴西
    • 哥倫比亞
    • 其他
  • 中東·非洲
    • 市場規模:各市場區隔(實際成果值·預測值)
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國
    • 其他

第9章 競爭情形

  • 擴大·收購
  • 夥伴關係·合作·契約·展示會

第10章 企業簡介

  • Cell Biologics, Inc.
  • ZenBio, Inc.
  • Stem Cell Technologies
  • Sigma-Aldrich
  • Thermo Fisher Scientific
  • Cureline
  • American Type Culture Collection
  • Cell Applications, Inc.
  • Pelobiotech
  • Merck KGaA
  • Axol Bioscience Ltd
  • Promocell
  • ALLCells
  • Lonza Group, AG
  • Creative Bioarray
目錄
Product Code: PM1840

The global primary cells market size is expected to reach USD 1.79 billion by 2028 according to a new study by Polaris Market Research. The report "Primary Cells Market Share, Size, Trends, Industry Analysis Report, By Type (Hematopoietic, Hepatocytes, Renal, Gastrointestinal, Skin, Lung); By End-Use (Medical, Pharmaceutical & Biotechnology Companies, Research Institutes); By Source; By Regions; Segment Forecast, 2021 - 2028" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing investments in biomedical research coupled with growth in the occurrence of diseases such as cancer drive the growth of the primary cell culture market. Increasing demand for advanced drug development and testing, growing applications in genetic engineering and virology, and stringent regulations regarding animal testing boost the growth of this market.

The significant growth in healthcare and pharmaceutical sectors, technological advancements, and growing use of primary cells in stem cell therapy are some factors expected to provide growth opportunities during the forecast period. The different types of primary cells include hematopoietic, hepatocytes, renal cells, gastrointestinal cells, skin cells, lung cells, and others. There has been a high demand for hematopoietic cells, which are derived from blood and bone marrow.

The demand for human primary cells was high in 2019. Human primary cells exhibit the functional and morphological characteristics of their tissue of origin. Human primary cells are increasingly being used in cancer research, and drug discovery. Other applications driving the growth of this segment include 3D cell culture, drug screening, and toxicity testing, monoclonal antibodies, and genetic engineering.

The increasing use of these cells for treatment and research associated with cancer, coupled with technological advancements drives the market growth. Hematopoietic primary cells are increasingly being used in stem cell therapy, vaccine development, and the study of tissue and organ replacement, thereby boosting the growth of this segment.

The demand for primary cells has increased from pharmaceutical and biotechnology companies for applications such as research and development, drug discovery, testing of new drugs, cosmetics, and chemicals, and analyzing of maximum permissible dosage of new drugs. The increasing investments in biomedical research, coupled with government initiatives support the growth of this segment.

North America dominated the global primary cell culture market in 2020 and is expected to maintain its dominance over the forecast period. Growing advancements in cancer research, significant investment in healthcare services, and the increasing occurrence of cancer-related disorders support market growth in this region. The increasing geriatric population coupled with government initiatives and programs, and emerging healthcare and pharmaceutical sectors fuel growth in this region.

Some major market participants include Cell Biologics, Inc., ZenBio, Inc., Stem Cell Technologies, Sigma-Aldrich, Thermo Fisher Scientific, Cureline, American Type Culture Collection, Cell Applications, Inc., Pelobiotech, Merck KGaA, Axol Bioscience Ltd, Promocell, ALLCells, Lonza Group, AG, and Creative Bioarray.

Polaris Market Research has segmented the primary cells market report on the basis of source, type, end-use, and region:

Primary Cells Source Outlook (Revenue, USD Million, 2016 - 2028)

Animal Primary Cells

Human Primary Cells

Primary Cells Type Outlook (Revenue, USD Million, 2016 - 2028)

Hematopoietic

Hepatocytes

Renal Cells

Gastrointestinal Cells

Skin Cells

Lung Cells

Others

Primary Cells End-Use Outlook (Revenue, USD Million, 2016 - 2028)

Medical

Pharmaceutical and Biotechnology Companies

Research Institutes

Others

Primary Cells Regional Outlook (Revenue, USD Million, 2016 - 2028)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

RoE

Asia Pacific

China

India

Japan

South Korea

RoAPAC

Latin America

Brazil

Mexico

Colombia

RoLATAM

Middle East & Africa

Saudi Arabia

South Africa

Israel

UAE

RoMEA

Table of Contents

1. Chapter 1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Chapter 2. Executive Summary

  • 2.1. Market Highlights

3. Chapter 3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Chapter 4. Primary Cells Market Insights

  • 4.1. Primary Cells - Industry snapshot
  • 4.2. Primary Cells Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Threats of New Entrants
    • 4.3.3. Bargaining Power of Buyers
    • 4.3.4. Threats of Substitute
    • 4.3.5. Rivalry among existing firms
  • 4.4. Primary Cells Market PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Competitive Ranking Analysis, 2020

5. Chapter 5. Primary Cells Market Assessment by Source

  • 5.1. Introduction
    • 5.1.1. Global Primary Cells Market Share, By Source, 2020 & 2028
  • 5.2. Animal Primary Cells
    • 5.2.1. Global Primary Cells Market, by Animal Primary Cells, 2016-2028 (USD Million)
    • 5.2.2. Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million)
  • 5.3. Human Primary Cells
    • 5.3.1. Global Primary Cells Market, by Human Primary Cells, 2016-2028 (USD Million)
    • 5.3.2. Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million)

6. Chapter 6. Primary Cells Market Assessment by Type

  • 6.1. Introduction
    • 6.1.1. Global Primary Cells Market Share, By Type, 2020 & 2028
  • 6.2. Hematopoietic
    • 6.2.1. Global Primary Cells Market, by Hematopoietic, 2016-2028 (USD Million)
    • 6.2.2. Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million)
  • 6.3. Hepatocytes
    • 6.3.1. Global Primary Cells Market, by Hepatocytes, 2016-2028 (USD Million)
    • 6.3.2. Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million)
  • 6.4. Renal Cells
    • 6.4.1. Global Primary Cells Market, by Renal Cells, 2016-2028 (USD Million)
    • 6.4.2. Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million)
  • 6.5. Gastrointestinal Cells
    • 6.5.1. Global Primary Cells Market, by Gastrointestinal Cells, 2016-2028 (USD Million)
    • 6.5.2. Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million)
  • 6.6. Skin Cells
    • 6.6.1. Global Primary Cells Market, by Skin Cells, 2016-2028 (USD Million)
    • 6.6.2. Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million)
  • 6.7. Lung Cells
    • 6.7.1. Global Primary Cells Market, by Lung Cells, 2016-2028 (USD Million)
    • 6.7.2. Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Primary Cells Market, by Others, 2016-2028 (USD Million)
    • 6.8.2. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)

7. Chapter 7. Primary Cells Market Assessment by End-User

  • 7.1. Introduction
    • 7.1.1. Global Primary Cells Market Share, By End-User, 2020 & 2028
  • 7.2. Medical
    • 7.2.1. Global Primary Cells Market, by Medical, 2016-2028 (USD Million)
    • 7.2.2. Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million)
  • 7.3. Pharmaceutical and Biotechnology Companies
    • 7.3.1. Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, 2016-2028 (USD Million)
    • 7.3.2. Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million)
  • 7.4. Research Institutes
    • 7.4.1. Global Primary Cells Market, by Research Institutes, 2016-2028 (USD Million)
    • 7.4.2. Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million)
  • 7.5. Others
    • 7.5.1. Global Primary Cells Market, by Others, 2016-2028 (USD Million)
    • 7.5.2. Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)

8. Chapter 8. Primary Cells Market Assessment by Geography

  • 8.1. Introduction
    • 8.1.1. Global Primary Cells Market Share, By Geography, 2020 & 2028.
  • 8.2. Primary Cells Market - North America
    • 8.2.1. North America: Primary Cells Market, by Country, 2016-2028 (USD Million)
    • 8.2.2. North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
    • 8.2.3. North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
    • 8.2.4. North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.2.5. Primary Cells Market - U.S.
      • 8.2.5.1. U.S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.2.5.2. U.S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.2.5.3. U.S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.2.6. Primary Cells Market - Canada
      • 8.2.6.1. Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.2.6.2. Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.2.6.3. Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • 8.3. Primary Cells Market - Europe
    • 8.3.1. Europe: Primary Cells Market, by Country, 2016-2028 (USD Million)
    • 8.3.2. Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
    • 8.3.3. Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
    • 8.3.4. Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.5. Primary Cells Market - Germany
      • 8.3.5.1. Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.5.2. Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.5.3. Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.6. Primary Cells Market - UK
      • 8.3.6.1. UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.6.2. UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.6.3. UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.7. Primary Cells Market - France
      • 8.3.7.1. France: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.7.2. France: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.7.3. France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.8. Primary Cells Market - Italy
      • 8.3.8.1. Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.8.2. Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.8.3. Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.9. Primary Cells Market - Spain
      • 8.3.9.1. Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.9.2. Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.9.3. Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.3.10. Primary Cells Market - Rest of Europe
      • 8.3.10.1. Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.3.10.2. Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.3.10.3. Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • 8.4. Primary Cells Market - Asia-Pacific
    • 8.4.1. Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million)
    • 8.4.2. Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
    • 8.4.3. Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
    • 8.4.4. Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.4.5. Primary Cells Market - China
      • 8.4.5.1. China: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.4.5.2. China: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.4.5.3. China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.4.6. Primary Cells Market - India
      • 8.4.6.1. India: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.4.6.2. India: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.4.6.3. India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.4.7. Primary Cells Market - Japan
      • 8.4.7.1. Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.4.7.2. Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.4.7.3. Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.4.8. Primary Cells Market - South Korea
      • 8.4.8.1. South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.4.8.2. South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.4.8.3. South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.4.9. Primary Cells Market - Rest of APAC
      • 8.4.9.1. Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.4.9.2. Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.4.9.3. Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • 8.5. Primary Cells Market - Latin America
    • 8.5.1. Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million)
    • 8.5.2. Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
    • 8.5.3. Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
    • 8.5.4. Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.5.5. Primary Cells Market - Brazil
      • 8.5.5.1. Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.5.5.2. Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.5.5.3. Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.5.6. Primary Cells Market - Mexico
      • 8.5.6.1. Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.5.6.2. Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.5.6.3. Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.5.7. Primary Cells Market - Colombia
      • 8.5.7.1. Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.5.7.2. Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.5.7.3. Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.5.8. Primary Cells Market - Rest of Latin America
      • 8.5.8.1. Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.5.8.2. Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.5.8.3. Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • 8.6. Primary Cells Market - Middle East and Africa
    • 8.6.1. Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million)
    • 8.6.2. Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
    • 8.6.3. Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
    • 8.6.4. Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.6.5. Primary Cells Market - Saudi Arabia
      • 8.6.5.1. Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.6.5.2. Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.6.5.3. Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.6.6. Primary Cells Market - South Africa
      • 8.6.6.1. South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.6.6.2. South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.6.6.3. South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.6.7. Primary Cells Market - Israel
      • 8.6.7.1. Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.6.7.2. Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.6.7.3. Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.6.8. Primary Cells Market - UAE
      • 8.6.8.1. UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.6.8.2. UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.6.8.3. UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
    • 8.6.9. Primary Cells Market - Rest of MEA
      • 8.6.9.1. Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
      • 8.6.9.2. Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
      • 8.6.9.3. Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)

9. Chapter 9. Competitive Landscape

  • 9.1. Expansion and Product Launch Analysis
    • 9.1.1. Expansion
    • 9.1.2. Product Launch
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Chapter 10. Company Profiles

  • 10.1. Cell Biologics, Inc.
    • 10.1.1. Business Overview
    • 10.1.2. Financial Snapshot
    • 10.1.3. Products and Services Benchmarking
    • 10.1.4. Recent Development
  • 10.2. ZenBio, Inc.
    • 10.2.1. Business Overview
    • 10.2.2. Financial Snapshot
    • 10.2.3. Products and Services Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Stem Cell Technologies
    • 10.3.1. Business Overview
    • 10.3.2. Financial Snapshot
    • 10.3.3. Products and Services Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Sigma-Aldrich
    • 10.4.1. Business Overview
    • 10.4.2. Financial Snapshot
    • 10.4.3. Products and Services Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Thermo Fisher Scientific
    • 10.5.1. Business Overview
    • 10.5.2. Financial Snapshot
    • 10.5.3. Products and Services Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Cureline
    • 10.6.1. Business Overview
    • 10.6.2. Financial Snapshot
    • 10.6.3. Products and Services Benchmarking
    • 10.6.4. Recent Development
  • 10.7. American Type Culture Collection
    • 10.7.1. Business Overview
    • 10.7.2. Financial Snapshot
    • 10.7.3. Products and Services Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Cell Applications, Inc.
    • 10.8.1. Business Overview
    • 10.8.2. Financial Snapshot
    • 10.8.3. Products and Services Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Pelobiotech
    • 10.9.1. Business Overview
    • 10.9.2. Financial Snapshot
    • 10.9.3. Products and Services Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck KGaA
    • 10.10.1. Business Overview
    • 10.10.2. Financial Snapshot
    • 10.10.3. Products and Services Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Axol Bioscience Ltd
    • 10.11.1. Business Overview
    • 10.11.2. Financial Snapshot
    • 10.11.3. Products and Services Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Promocell
    • 10.12.1. Business Overview
    • 10.12.2. Financial Snapshot
    • 10.12.3. Products and Services Benchmarking
    • 10.12.4. Recent Development
  • 10.13. ALLCells
    • 10.13.1. Business Overview
    • 10.13.2. Financial Snapshot
    • 10.13.3. Products and Services Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Lonza Group, AG
    • 10.14.1. Business Overview
    • 10.14.2. Financial Snapshot
    • 10.14.3. Products and Services Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Creative Bioarray
    • 10.15.1. Business Overview
    • 10.15.2. Financial Snapshot
    • 10.15.3. Products and Services Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Drivers and Inhibitors for Global Market
  • Table 2 Restraints Global Market
  • Table 3 Global Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 4 Global Primary Cells Market, by Animal Primary Cells, by Region, 2016-2028 (USD Million)
  • Table 5 Global Primary Cells Market, by Human Primary Cells, by Region, 2016-2028 (USD Million)
  • Table 6 Global Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 7 Global Primary Cells Market, by Hematopoietic, by Region, 2016-2028 (USD Million)
  • Table 8 Global Primary Cells Market, by Hepatocytes, by Region, 2016-2028 (USD Million)
  • Table 9 Global Primary Cells Market, by Renal Cells, by Region, 2016-2028 (USD Million)
  • Table 10 Global Primary Cells Market, by Gastrointestinal Cells, by Region, 2016-2028 (USD Million)
  • Table 11 Global Primary Cells Market, by Skin Cells, by Region, 2016-2028 (USD Million)
  • Table 12 Global Primary Cells Market, by Lung Cells, by Region, 2016-2028 (USD Million)
  • Table 13 Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 14 Global Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 15 Global Primary Cells Market, by Medical, by Region, 2016-2028 (USD Million)
  • Table 16 Global Primary Cells Market, by Pharmaceutical and Biotechnology Companies, by Region, 2016-2028 (USD Million)
  • Table 17 Global Primary Cells Market, by Research Institutes, by Region, 2016-2028 (USD Million)
  • Table 18 Global Primary Cells Market, by Others, by Region, 2016-2028 (USD Million)
  • Table 19 Global Primary Cells Market, By Geography, 2016 - 2028 (USD Million)
  • Table 20 North America: Primary Cells Market, by Country, 2016-2028 (USD Million)
  • Table 21 North America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 22 North America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 23 North America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 24 U.S.: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 25 U.S.: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 26 U.S.: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 27 Canada: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 28 Canada: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 29 Canada: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 30 Europe: Primary Cells Market, by Country, 2016-2028 (USD Million)
  • Table 31 Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 32 Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 33 Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 34 Germany: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 35 Germany: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 36 Germany: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 37 UK: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 38 UK: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 39 UK: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 40 France: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 41 France: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 42 France: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 43 Italy: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 44 Italy: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 45 Italy: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 46 Spain: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 47 Spain: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 48 Spain: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 49 Rest of Europe: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 50 Rest of Europe: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 51 Rest of Europe: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 52 Asia Pacific: Primary Cells Market, by Country, 2016-2028 (USD Million)
  • Table 53 Asia-Pacific: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 54 Asia-Pacific: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 55 Asia-Pacific: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 56 China: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 57 China: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 58 China: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 59 India: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 60 India: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 61 India: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 62 Japan: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 63 Japan: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 64 Japan: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 65 South Korea: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 66 South Korea: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 67 South Korea: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 68 Rest of APAC: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 69 Rest of APAC: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 70 Rest of APAC: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 71 Latin America: Primary Cells Market, by Country, 2016-2028 (USD Million)
  • Table 72 Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 73 Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 74 Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 75 Brazil: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 76 Brazil: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 77 Brazil: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 78 Mexico: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 79 Mexico: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 80 Mexico: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 81 Colombia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 82 Colombia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 83 Colombia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 84 Rest of Latin America: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 85 Rest of Latin America: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 86 Rest of Latin America: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 87 Middle East & Africa: Primary Cells Market, by Country, 2016-2028 (USD Million)
  • Table 88 Middle East & Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 89 Middle East & Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 90 Middle East & Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 91 Saudi Arabia: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 92 Saudi Arabia: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 93 Saudi Arabia: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 94 South Africa: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 95 South Africa: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 96 South Africa: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 97 Israel: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 98 Israel: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 99 Israel: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 100 UAE: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 101 UAE: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 102 UAE: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)
  • Table 103 Rest of MEA: Primary Cells Market, By Source, 2016 - 2028 (USD Million)
  • Table 104 Rest of MEA: Primary Cells Market, By Type, 2016 - 2028 (USD Million)
  • Table 105 Rest of MEA: Primary Cells Market, By End-User, 2016 - 2028 (USD Million)

List of Figures

FIG. 1 Market snapshot

FIG. 2 Market segmentation & scope

FIG. 3 Global Primary Cells market size and growth prospects, 2016 - 2028

FIG. 4 Value chain analysis

FIG. 5 Primary Cells market dynamics

FIG. 6 Key market opportunities - prioritized

FIG. 7 Industry analysis - Porter's

FIG. 8 PESTEL analysis

FIG. 9 Global Primary Cells market share by Source, 2020 & 2028

FIG. 10 Global Primary Cells market share by Type, 2020 & 2028

FIG. 11 Global Primary Cells market share by End-User, 2020 & 2028

FIG. 12 Global Primary Cells market share by Region, 2020 & 2028

FIG. 13 Competitive environment

FIG. 14 Strategy framework